Related Experiment Video
Updated: Feb 16, 2026

An Electroporation Method to Transform Rickettsia spp. with a Fluorescent Protein-Expressing Shuttle Vector in Tick Cell Lines
Published on: October 11, 2022
The expression and modulation of CEACAM1 and tumor cell transformation
Valentina Fiori1, Mauro Magnani, Maurizio Cianfriglia
1Diatheva srl, Fano (PU), Italy.
Background:
In this review, we focus our discussion on one class of carcinoembryonic antigen- related cell adhesion molecules, Carcinoembryonic antigen-related cell adhesion molecules 1 (CEACAM1). This has been observed in several malignant transformations to be subjected to complex mechanisms of modulation and dysregulation.
Aims:
Restoration of CEACAM1 expression in tumor cell lines often abolishes their oncogenicity in vivo, and therefore, this adhesion molecule has been regarded as a tumor suppressor. In contrast, de novo expression of CEACAM1 is found with the progression of malignancy and metastatic spread in a large array of cancer tissues which include melanoma, Non Small Cell Lung Carcinoma (NSCLC) as well as bladder, prostate, thyroid, breast, colon and gastric carcinomas.
Discussion:
We report and discuss the most significant findings confirming at immunohistochemical and clinical level the correlation between poor prognosis and expression of CEACAM1 on the cell surface of tumors.
Insights
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) acts as a tumor suppressor when its expression is restored. However, its de novo expression correlates with advanced cancers and poor prognosis in various tumor types.
Area of Science:
- Oncology
- Cell Adhesion Molecules
- Cancer Biology
Background:
- Focuses on Carcinoembryonic antigen-related cell adhesion molecules 1 (CEACAM1), a key molecule in cell adhesion.
- Highlights CEACAM1's complex modulation and dysregulation in malignant transformations.
Purpose of the Study:
- To review the dual role of CEACAM1 in cancer, as both a potential tumor suppressor and a marker of malignancy.
- To investigate the correlation between CEACAM1 expression and patient prognosis.
Main Methods:
- Literature review focusing on CEACAM1.
- Immunohistochemical analysis of CEACAM1 expression in various tumor tissues.
- Clinical data correlation with CEACAM1 expression levels.
Main Results:
- Restoration of CEACAM1 expression can abolish tumor cell oncogenicity in vivo.
- De novo CEACAM1 expression is observed in advanced stages of melanoma, NSCLC, and other carcinomas.
- Immunohistochemical and clinical data confirm a correlation between CEACAM1 cell surface expression and poor prognosis.
Conclusions:
- CEACAM1 exhibits context-dependent roles in cancer progression.
- CEACAM1 expression on tumor cells is a significant indicator of poor prognosis.
- Further research into CEACAM1's therapeutic potential is warranted.
Related Concept Videos
Transformation
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Cell Specific Gene Expression
Cell Specific Gene Expression
Transformers
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...

